CDIO is trading at $2.05 (+1.49%) as it extends momentum from investor interest in its Atlas Healthcare Physicians partnership and AI-driven epigenetics diagnostics story.

  • The gain appears company-specific as broader markets are lower, with the S&P 500 down 0.53% and the Nasdaq down 0.89%.
  • The move follows a volatile period including a 7.73% drop on June 24 and an 8.7% after-hours jump on June 25, suggesting continued headline-driven activity.